Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success
- DOI
- 10.1136/bmjresp-2026-004232
- Published
- 2026-07
- Container
- BMJ Open Respiratory Research
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjresp-2026-004232,
title = {Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success},
author = {Rachel Burton and Maria Puthoor and Fred Fyles and Lisa Lewis and Hannah Joplin and Hassan Burhan},
year = {2026},
journal = {BMJ Open Respiratory Research},
doi = {10.1136/bmjresp-2026-004232},
url = {https://doi.org/10.1136/bmjresp-2026-004232}
}RIS
TY - JOUR TI - Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success AU - Rachel Burton AU - Maria Puthoor AU - Fred Fyles AU - Lisa Lewis AU - Hannah Joplin AU - Hassan Burhan PY - 2026 JO - BMJ Open Respiratory Research DO - 10.1136/bmjresp-2026-004232 UR - https://doi.org/10.1136/bmjresp-2026-004232 ER -
APA
Burton, R., Puthoor, M., Fyles, F., Lewis, L., Joplin, H., & Burhan, H. (2026). Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success. BMJ Open Respiratory Research. https://doi.org/10.1136/bmjresp-2026-004232
Source records
- crossref · retrieved 2026-11-10T13:41:29.011Z